Intellia Therapeutics Company
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Investors
Connections from
Total Funding:
775000000
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Employee Number:
251-500
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2021-06-30
Investors Number:
9
Founded Date:
1/1/2014
Industry:
Gene therapy